Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Effects on NSCLC using FLT-PET
NCT02819024Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jun 2016
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in non-small cell lung cancer (NSCLC), sponsored by Barbara Ann Karmanos Cancer Institute. Primary endpoint: Change in Tumor SUVmax Assessed by 18F-FLT PET Imaging at Day 9. Started Jun 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02819024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819024.